Literature DB >> 31609246

Atrial fibrillation risk loci interact to modulate Ca2+-dependent atrial rhythm homeostasis.

Brigitte Laforest1, Wenli Dai2, Leonid Tyan3, Sonja Lazarevic1, Kaitlyn M Shen1, Margaret Gadek1, Michael T Broman3, Christopher R Weber2, Ivan P Moskowitz1,2.   

Abstract

Atrial fibrillation (AF), defined by disorganized atrial cardiac rhythm, is the most prevalent cardiac arrhythmia worldwide. Recent genetic studies have highlighted a major heritable component and identified numerous loci associated with AF risk, including the cardiogenic transcription factor genes TBX5, GATA4, and NKX2-5. We report that Tbx5 and Gata4 interact with opposite signs for atrial rhythm controls compared with cardiac development. Using mouse genetics, we found that AF pathophysiology caused by Tbx5 haploinsufficiency, including atrial arrhythmia susceptibility, prolonged action potential duration, and ectopic cardiomyocyte depolarizations, were all rescued by Gata4 haploinsufficiency. In contrast, Nkx2-5 haploinsufficiency showed no combinatorial effect. The molecular basis of the TBX5/GATA4 interaction included normalization of intra-cardiomyocyte calcium flux and expression of calcium channel genes Atp2a2 and Ryr2. Furthermore, GATA4 and TBX5 showed antagonistic interactions on an Ryr2 enhancer. Atrial rhythm instability caused by Tbx5 haploinsufficiency was rescued by a decreased dose of phospholamban, a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, consistent with a role for decreased sarcoplasmic reticulum calcium flux in Tbx5-dependent AF susceptibility. This work defines a link between Tbx5 dose, sarcoplasmic reticulum calcium flux, and AF propensity. The unexpected interactions between Tbx5 and Gata4 in atrial rhythm control suggest that evaluating specific interactions between genetic risk loci will be necessary for ascertaining personalized risk from genetic association data.

Entities:  

Keywords:  Arrhythmias; Calcium; Cardiology; Genetics; Transcription

Mesh:

Substances:

Year:  2019        PMID: 31609246      PMCID: PMC6819107          DOI: 10.1172/JCI124231

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

2.  Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.

Authors:  Joachim P Schmitt; Mitsuhiro Kamisago; Michio Asahi; Guo Hua Li; Ferhaan Ahmad; Ulrike Mende; Evangelia G Kranias; David H MacLennan; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

Review 3.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

4.  GATA4 is essential for formation of the proepicardium and regulates cardiogenesis.

Authors:  Alistair J Watt; Michele A Battle; Jixuan Li; Stephen A Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

5.  The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system.

Authors:  Ivan P G Moskowitz; Anne Pizard; Vickas V Patel; Benoit G Bruneau; Jae B Kim; Sabina Kupershmidt; Dan Roden; Charles I Berul; Christine E Seidman; Jonathan G Seidman
Journal:  Development       Date:  2004-08       Impact factor: 6.868

Review 6.  Transcription factors and atrial fibrillation.

Authors:  Saagar Mahida
Journal:  Cardiovasc Res       Date:  2013-11-21       Impact factor: 10.787

7.  Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.

Authors:  Manami Kaneko; Kentarou Hashikami; Satoshi Yamamoto; Hirokazu Matsumoto; Tomoyuki Nishimoto
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

8.  A calcium transport mechanism for atrial fibrillation in Tbx5-mutant mice.

Authors:  Wenli Dai; Brigitte Laforest; Leonid Tyan; Kaitlyn M Shen; Rangarajan D Nadadur; Francisco J Alvarado; Stefan R Mazurek; Sonja Lazarevic; Margaret Gadek; Yitang Wang; Ye Li; Hector H Valdivia; Le Shen; Michael T Broman; Ivan P Moskowitz; Christopher R Weber
Journal:  Elife       Date:  2019-03-21       Impact factor: 8.140

9.  Genome-wide association study of PR interval.

Authors:  Arne Pfeufer; Charlotte van Noord; Kristin D Marciante; Dan E Arking; Martin G Larson; Albert Vernon Smith; Kirill V Tarasov; Martina Müller; Nona Sotoodehnia; Moritz F Sinner; Germaine C Verwoert; Man Li; W H Linda Kao; Anna Köttgen; Josef Coresh; Joshua C Bis; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Fernando Rivadeneira; Albert Hofman; Jan A Kors; Bruno H C Stricker; André G Uitterlinden; Cornelia M van Duijn; Britt M Beckmann; Wiebke Sauter; Christian Gieger; Steven A Lubitz; Christopher Newton-Cheh; Thomas J Wang; Jared W Magnani; Renate B Schnabel; Mina K Chung; John Barnard; Jonathan D Smith; David R Van Wagoner; Ramachandran S Vasan; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Lenore J Launer; Samer S Najjar; Edward Lakatta; David Schlessinger; Manuela Uda; Gonçalo R Abecasis; Bertram Müller-Myhsok; Georg B Ehret; Eric Boerwinkle; Aravinda Chakravarti; Elsayed Z Soliman; Kathryn L Lunetta; Siegfried Perz; H-Erich Wichmann; Thomas Meitinger; Daniel Levy; Vilmundur Gudnason; Patrick T Ellinor; Serena Sanna; Stefan Kääb; Jacqueline C M Witteman; Alvaro Alonso; Emelia J Benjamin; Susan R Heckbert
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

Review 10.  The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective.

Authors:  Carl Hayward; Nicholas R Banner; Andrew Morley-Smith; Alexander R Lyon; Sian E Harding
Journal:  Hum Gene Ther       Date:  2015-05       Impact factor: 5.695

View more
  16 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Afterdepolarizations and abnormal calcium handling in atrial myocytes with modulated SERCA uptake: a sensitivity analysis of calcium handling channels.

Authors:  Andy C Y Lo; Jieyun Bai; Patrick A Gladding; Vadim V Fedorov; Jichao Zhao
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2020-05-25       Impact factor: 4.226

3.  Acupuncture as an adjunctive therapy for arrhythmia: a Delphi expert consensus survey.

Authors:  Jin-Ling Li; Li-Qiong Wang; Na Zhang; Xin-Tong Su; Ying Lin; Jing-Wen Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Cardiovasc Diagn Ther       Date:  2021-10

4.  Partial and complete loss of myosin binding protein H-like cause cardiac conduction defects.

Authors:  David Y Barefield; Sean Yamakawa; Ibrahim Tahtah; Jordan J Sell; Michael Broman; Brigitte Laforest; Sloane Harris; Alejandro Alvarez-Arce; Kelly N Araujo; Megan J Puckelwartz; J Andrew Wasserstrom; Glenn I Fishman; Elizabeth M McNally
Journal:  J Mol Cell Cardiol       Date:  2022-05-06       Impact factor: 5.763

5.  Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.

Authors:  Irfan S Kathiriya; Kavitha S Rao; Giovanni Iacono; W Patrick Devine; Andrew P Blair; Swetansu K Hota; Michael H Lai; Bayardo I Garay; Reuben Thomas; Henry Z Gong; Lauren K Wasson; Piyush Goyal; Tatyana Sukonnik; Kevin M Hu; Gunes A Akgun; Laure D Bernard; Brynn N Akerberg; Fei Gu; Kai Li; Matthew L Speir; Maximilian Haeussler; William T Pu; Joshua M Stuart; Christine E Seidman; J G Seidman; Holger Heyn; Benoit G Bruneau
Journal:  Dev Cell       Date:  2020-12-14       Impact factor: 12.270

6.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

Review 7.  Transcriptional factors in calcium mishandling and atrial fibrillation development.

Authors:  Wenli Dai; Sneha Kesaraju; Christopher R Weber
Journal:  Pflugers Arch       Date:  2021-05-18       Impact factor: 4.458

Review 8.  Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.

Authors:  Xin-Ming Liu; Sheng-Li Du; Ran Miao; Le-Feng Wang; Jiu-Chang Zhong
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

9.  TBX5-encoded T-box transcription factor 5 variant T223M is associated with long QT syndrome and pediatric sudden cardiac death.

Authors:  Alexandra M Markunas; Perathu K R Manivannan; Jordan E Ezekian; Agnim Agarwal; William Eisner; Katherina Alsina; Hugh D Allen; Gregory A Wray; Jeffrey J Kim; Xander H T Wehrens; Andrew P Landstrom
Journal:  Am J Med Genet A       Date:  2020-12-23       Impact factor: 2.802

Review 10.  Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation.

Authors:  Antoinette F van Ouwerkerk; Amelia W Hall; Zachary A Kadow; Sonja Lazarevic; Jasmeet S Reyat; Nathan R Tucker; Rangarajan D Nadadur; Fernanda M Bosada; Valerio Bianchi; Patrick T Ellinor; Larissa Fabritz; James F Martin; Wouter de Laat; Paulus Kirchhof; Ivan P Moskowitz; Vincent M Christoffels
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.